# Evaluation of GM101 Injection in Patients With Parkinson's Disease

> **NCT07100171** · EARLY_PHASE1 · RECRUITING · sponsor: **Genemagic Biosciences Co., Ltd** · enrollment: 10 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **OTHER:** Biological: GM101

## Key facts

- **NCT ID:** NCT07100171
- **Lead sponsor:** Genemagic Biosciences Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-29
- **Primary completion:** 2027-02-17
- **Final completion:** 2030-02-17
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07100171

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07100171, "Evaluation of GM101 Injection in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07100171. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*